The Bcl-2 family member BIM has multiple glaucoma-relevant functions in DBA/2J mice

Jeffrey M Harder1, Kimberly A Fernandes, Richard T Libby

  • 1Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.

Scientific Reports
|July 27, 2012
PubMed

Insights

BIM deficiency delayed retinal ganglion cell death after optic nerve injury but did not prevent it in glaucoma models. In DBA/2J mice, Bim deficiency altered glaucoma progression, suggesting multiple roles for BIM in eye disease.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Molecular Biology

Background:

  • Axonal injury triggers retinal ganglion cell (RGC) death via BAX activation.
  • The pro-apoptotic protein BIM promotes BAX activation and is upregulated after axonal injury, dependent on JUN.
  • Previous studies showed Bim deficiency delays RGC death after mechanical optic nerve injury.

Purpose of the Study:

  • To investigate the role of BIM in RGC death and glaucoma pathophysiology.
  • To determine if BIM deficiency impacts disease progression in a genetic glaucoma mouse model (DBA/2J).

Main Methods:

  • Utilized mechanical optic nerve injury models to assess RGC survival in Bim-deficient mice.
  • Examined DBA/2J mice with genetic glaucoma, comparing Bim-deficient and wild-type littermates.
  • Assessed RGC survival, optic nerve damage, optic nerve head morphology, and intraocular pressure.

Main Results:

  • Bim deficiency delayed RGC death following mechanical optic nerve injury.
  • In DBA/2J mice, Bim deficiency did not prevent RGC death in advanced glaucoma but altered disease progression in a subset of mice.
  • Bim deficiency in DBA/2J mice led to less severe optic nerve damage, altered optic nerve head morphology, and reduced intraocular pressure elevation.

Conclusions:

  • BIM has a direct role in RGC death following mechanical injury.
  • In the context of glaucoma, BIM's role is complex, potentially influencing susceptibility through mechanisms beyond direct RGC apoptosis, such as affecting intraocular pressure and optic nerve head pathology.
  • These findings suggest BIM is a potential therapeutic target for glaucoma, with multifaceted roles in disease pathogenesis.